'Knockoff' Blood Clot Product Still On Market: Supplement Co.

Law360, New York (March 11, 2013, 7:47 PM EDT) -- Daniels Health Sciences LLC asked a Texas federal court on Monday to hold Vascular Health Sciences LLC in contempt for not complying with a preliminary injunction blocking it from marketing or selling a purported knockoff version of Daniels’ arterial blood clot reduction supplement Provasca.

As of early Monday, Daniels Health said Vascular was still selling and marketing its version of the dietary supplement, called Arterosil, even after the Fifth Circuit upheld the injunction on March 5 in light of available evidence that Vascular allegedly misappropriated trade...
To view the full article, register now.